Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study

Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study

Post-marketing surveillance activities are essential to detect the risk/benefit profile of biologic disease-modifying antirheumatic drugs (bDMARDs) in inflammatory arthritis. The aim of this study was to evaluate adverse events (AEs) in patients treated with bDMARDs in rheumatology during a prospect...

Full description

Bibliographic Details
Main Authors: Maria Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Elisabetta Gerratana, Caterina Palleria, Caterina De Sarro, Ada Vero, Luigi Iannone, Antonia Manti, Emilio Russo, Giovambattista De Sarro, Fabiola Atzeni, Edoardo Spina
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
pharmacovigilance
biologic drugs
inflammatory arthritis
adverse events
real-world data
treatment failure
Online Access:https://www.mdpi.com/2077-0383/9/4/1227

Similar Items

Similar Items